MarkChristopherGenoveseMD
Rheumatology • Palo Alto, CARheumatoid Arthritis & Related, Vasculitis
SVP Immunology Clinical Development Eli Lilly and Company Professor, Medicine Emeritus Active - Immunology & Rheumatology, Stanford University Medical Center
Dr. Genovese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-723-6961Fax+1 650-725-8418- Is this information wrong?
Summary
- Dr. Mark Genovese is a rheumatologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and VA Palo Alto Health Care System. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 25 years. He specializes in rheumatoid arthritis & related and vasculitis and is experienced in severity of illness index.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 1996 - 1998- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1992 - 1995
Johns Hopkins University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1993 - 2024- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACP) American College of Physicians, 2003
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis Start of enrollment: 2005 Jun 01
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsA double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.Matthew C Baker, Audra Horomanski, Yiwen Wang, Liu Yuhan, Shima Parsafar, Robert Fairchild, Joshua J Mooney, Rishi Raj, Ronald Witteles, Mark C Genovese> ;Rheumatology. 2023 Jul 20
- 6 citationsA Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.Matthew C Baker, Sarah Kavanagh, Stanley Cohen, Alan K Matsumoto, Ara Dikranian, John Tesser, Alan Kivitz, Konstantinos Alataris, Mark C Genovese> ;Arthritis & Rheumatology. 2023 Dec 1
- 1 citationsA plain language summary of what clinical studies can tell us about the safety of evobrutinib - a potential treatment for multiple sclerosis.Xavier Montalban, Daniel Wallace, Mark C Genovese, Davorka Tomic, Dana Parsons-Rich, Claire Le Bolay, Amy H Kao, Hans Guehring> ;Neurodegenerative Disease Management. 2023 Aug 1
- Join now to see all
Journal Articles
- ABT‐122, a Bispecific DVD‐Immunoglobulin Targeting TNF– and IL‐17A, in RA with Inadequate Response to Methotrexate: A Randomized, Double‐Blind StudyMichael E Weinblatt, Mark C Genovese, Jacob A Aelion, Arthritis & Rheumatology
Press Mentions
Studies Probe Treating Rheumatoid Arthritis with Vagus Nerve StimulationJune 14th, 2021- Gilead Inks Deal with Novo Nordisk to Collaborate on NASH Treatment Leading to Phase 2b Study Using Cilofexor and FirsocostatMarch 19th, 2021
- Gilead and Novo Nordisk Expand NASH Clinical CollaborationMarch 18th, 2021
- Join now to see all
Grant Support
- Clinical Trial: Rituximab With Or Without Methotrex In Psoriatic Arthritis And PNational Center For Research Resources2008
- Study Of Taci-Fc5 In Patients With Systemic Lupus Erythematosus (SLE)National Center For Research Resources2007
- Fontolizumab In Subjects With Active Rheumatoid ArthritisNational Center For Research Resources2007
- Tumor Necrosis Factor-Alpha Inhibition (ADALIMUMAB) In OsteoarthritisNational Center For Research Resources2006–2007
- Study Of Taci-Fc5 Administered To Patients With Systemic Lupus ErythematosusNational Center For Research Resources2005–2006
- Monoclonal Anti-Blys Antibody In Subjects With Systemic Lupus ErythematosusNational Center For Research Resources2005–2006
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
Stanford Health CarePalo Alto, California
VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
